Skip to content

Infinion CXRecalls & reported problems across all models

Boston Scientific Neuromodulation Corporation · 2 models in the FDA device registry

Data updated Oct 16, 2026 from official FDA records · Editorial policy

1 open recall names at least one Infinion CX model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.

Adverse event reports
2,139
Deaths reported
1
Injuries reported
1,864
Recalls
1

We found 2 models of Infinion CX by Boston Scientific Neuromodulation Corporation in the FDA's device registry (GUDID). Together they are named in 2,139 adverse event reports in the FDA's MAUDE database, received between Jan 2, 2017 and Sep 28, 2026 — classified as 1 death, 1,864 injuries, 274 malfunctions.

The most frequently reported specific device problem is “High impedance” (1,306 reports).

1 FDA recall record name at least one of these models by its device identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Reports received per month, all models

Nov 2023: 34 reportsDec 2023: 36 reportsJan 2024: 23 reportsFeb 2024: 30 reportsMar 2024: 39 reportsApr 2024: 37 reportsMay 2024: 28 reportsJun 2024: 23 reportsJul 2024: 18 reportsAug 2024: 26 reportsSep 2024: 16 reportsOct 2024: 34 reportsNov 2024: 32 reportsDec 2024: 25 reportsJan 2025: 33 reportsFeb 2025: 16 reportsMar 2025: 32 reportsApr 2025: 16 reportsMay 2025: 27 reportsJun 2025: 19 reportsJul 2025: 23 reportsAug 2025: 20 reportsSep 2025: 17 reportsOct 2025: 24 reportsNov 2025: 19 reportsDec 2025: 27 reportsJan 2026: 18 reportsFeb 2026: 16 reportsMar 2026: 15 reportsApr 2026: 3 reportsMay 2026: 12 reportsJun 2026: 6 reportsJul 2026: 8 reportsAug 2026: 11 reportsSep 2026: 10 reportsOct 2026: 0 reports20242025202639
Last 36 months. The most recent month may be incomplete.

Infinion CX recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

  1. Jun 17, 2026Open, Classified

    Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, including lead explant and replacement.

    Z-2879-2026 · Root cause: Device Design · names 2 of these models · Recall details · FDA record ↗

Most reported Infinion CX problems

Device problems

  • High impedance1,306
  • Unexpected Therapeutic Results1,216
  • Migration598
  • Fracture322
  • Adverse Event Without Identified Device or Use Problem201
  • Inappropriate/Inadequate Shock/Stimulation41
  • Charging Problem32
  • Defective Device25

Patient problems

  • No Clinical Signs, Symptoms or Conditions671
  • Pain565
  • Inadequate Pain Relief449
  • No Code Available419
  • Undesired Nerve Stimulation100
  • Discomfort46
  • No Known Impact Or Consequence To Patient35
  • Cerebrospinal Fluid Leakage34

Infinion CX models

2 models, most reported first. Each model has its own page with its reports, recalls and device details.

Recent Infinion CX adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

Other Boston Scientific Neuromodulation Corporation products

All Boston Scientific Neuromodulation Corporation devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page